Purchase Order 36C24426P0225
- Not listed
- Nuclear Diagnostic Products, Inc. was awarded a two-year, firm fixed price delivery order valued at approximately $1.9 million by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA VHA VISN 2) to provide general radiopharmaceuticals. The contract has a period of performance starting February 22, 2021 through February 21, 2023, with all work to be conducted by the prime contractor at its facility located in Rockaway, New Jersey. No major...
- The Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Nuclear Diagnostic Products, Inc., a for-profit organization, to provide general radiopharmaceuticals for the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in New York and New Jersey. This $610,950.85 contract has a completion date of February 21, 2024. Nuclear Diagnostic Products, Inc. is the prime contractor and has been awarded numerous similar contracts by the VA...
- This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit company specializing in the supply of radiopharmaceuticals for the VA healthcare system. The $111,392.95 delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $4,038,178.15 with the VA's Veterans Integrated Service Network (VISN) 2 for general radiopharmaceuticals, with a performance period through February 2026. The contract does not...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a $285,808.53 firm fixed price delivery order to Nuclear Diagnostic Products, Inc. of Cherry Hill, New Jersey for radiopharmaceuticals. The contract has a completion date of March 14, 2022 and was awarded on March 15, 2021 without a set-aside designation. Nuclear Diagnostic Products, Inc. will provide radiopharmaceutical products to support imaging and diagnostic services for...
- This delivery order, valued at $908,629, was awarded to Nuclear Diagnostic Products, Inc. by Veterans Integrated Service Network (VISN) 2, a civilian agency under the Department of Veterans Affairs, with a performance location in Rockaway, New Jersey. The award represents a modification to de-obligate unused fiscal year 2024 funds under an existing contract structure. Nuclear Diagnostic Products, Inc., headquartered in Rockaway, New Jersey, is a specialized supplier of radiopharmaceuticals to...
- This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization that provides radiopharmaceuticals used in nuclear medicine procedures. The $288,366.34 contract is for the supply of radiopharmaceuticals to VA medical centers in Veterans Integrated Service Networks (VISNs) 2 and 4, which cover facilities in New York, New Jersey, Pennsylvania, and Delaware. The award is not set aside for any...
- The U.S. Department of Veterans Affairs Veterans Integrated Service Network 4 (VISN 4) awarded a delivery order modification to Nuclear Diagnostic Products, Inc. on March 15, 2025, to increase contract line item numbers (CLINs) for radiopharmaceutical products. The award, valued at $374.3K, is issued as a firm fixed-price delivery order against an existing Indefinite Delivery Contract (IDC) with a ceiling value through November 2027. This delivery order is not set-aside and will be performed...
- This federal contract award, valued at $103,865.20, was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc. for the provision of general radiopharmaceuticals to support the Veterans Integrated Service Network (VISN) 2 healthcare system. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the company, which provides specialized radiopharmaceutical products to VA medical centers in the northeastern United States....
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Nuclear Diagnostic Products, Inc., a for-profit organization, on May 2, 2018. The $107,176.03 contract is for the provision of radiopharmaceuticals to support nuclear medicine imaging procedures for veterans at VA facilities in VISN 4, which covers Pennsylvania and Delaware. Nuclear Diagnostic Products, Inc. is an established prime vendor of radiopharmaceuticals to the...
- This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in the supply of radiopharmaceuticals. The contract, valued at $174,071.55, is for the delivery of general radiopharmaceuticals to support nuclear medicine imaging procedures across the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in the northeastern United States. This contract is part of a larger Indefinite...
Nuclear Diagnostic Products, Inc., headquartered in Rockaway, New Jersey, was awarded a $148,382.50 firm fixed-price purchase order by Veterans Integrated Service Network 4 (VISN 4) on March 15, 2026, for the supply of radiopharmaceuticals and calibration sources. The contract will be performed in Philadelphia, Pennsylvania, with a completion date of September 30, 2026. This award was made without a set-aside designation and represents a delivery order against the company's existing Indefinite Delivery Contract with VA-Veterans Health Administration VISN 4 for ILLUCCIX (Gallium 68 PSMA-11), a specialized radiopharmaceutical used in positron emission tomography diagnostic imaging procedures. The underlying IDC, valued at $4.99 million, extends through November 2027 and provides the VA with continued access to this critical nuclear medicine imaging compound to support diagnostic services for veterans across the region. Nuclear Diagnostic Products, Inc. has established itself as a key supplier of radiopharmaceuticals to the federal healthcare market, with a demonstrated track record of delivering specialized medical imaging compounds to VA medical centers throughout the northeastern United States. The company maintains multiple indefinite delivery contracts with the VA, including a $4.04 million general radiopharmaceuticals contract with VISN 2 covering New York and New Jersey facilities. Through these vehicles, the company consistently supplies essential diagnostic products that enable nuclear medicine imaging procedures critical to veteran healthcare delivery, with prior delivery orders ranging from approximately $100,000 to nearly $1 million.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $148.4k | 3/16/26 |